Original Investigation

Cue-Elicited Brain Activity and Treatment Outcomes in Substance Use Disorders

JAMA Network Open 10.1001/jamanetworkopen.2025.48809

December 11, 2025 at 11:00 AM EST

Read the full article

Can functional magnetic resonance imaging (fMRI) cue reactivity serve as a predictive biomarker or response biomarker of treatment outcomes in individuals with substance use disorders?This meta-analysis of 51 fMRI cue reactivity studies with 1757 participants identified consistent cue-elicited brain activation patterns. Lower baseline activation in the insula and cingulate was associated with better treatment outcomes, whereas regions including the cingulate, caudate, accumbens, and insula, showed reduced activation following treatment.fMRI cue reactivity shows promise as a predictive biomarker and response biomarker for substance use disorder treatment, supporting its potential utility in guiding and evaluating therapeutic interventions.

Corresponding Author: Jodi M. Gilman, PhD, Center for Addiction Medicine, Department of Psychiatry, Massachusetts General Hospital, 101 Merrimac St, Ste 320, Boston, MA 02114 (jgilman1@mgh.harvard.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks